Challenges & opportunities
As a 2024 Vogue Codes Future Innovators Awards finalist, Furnell says she has known since her teenage years that she wanted to harness natural systems to improve lives. This includes supporting stable and sustainable supply chains for renewable materials, as part of the renewable energy transition.
Sörzero is a passion project that Furnell and her business partners created as a test of resilience to pressure test their team dynamic.
Furnell and Ismat Kabbara met while completing their research studies at the UNSW School of Biotechnology & Biomolecular Sciences. In 2021, they joined forces with Vivid Savitri-Hampton, a seasoned startup founder and product designer. They met when Furnell and Kabbara attended a mentorship program facilitated by the UNSW Founders program. The success of Sörzero validated the trio’s strength as a team and provided the foundation for further impact.
“Together, the three of us are also the founders of Synbiote,” Furnell says. “We are developing biomaterials to replace non-renewable materials in industry, starting with the energy sector.”
Synbiote’s focus is on creating sustainable and resilient solutions to mitigate the effects of climate change. As CEO, Furnell brings her background in commercial biotechnology to the group, having also conducted her honours project on commercialising Antarctic fungi at UNSW.
“I love the startup space, it’s where I know I can make the most impact with my work.”
At the start of Synbiote’s development, the team received a grant of USD$100,000 from Alexis Ohanian – the founder of 776 Foundation and cofounder of Reddit – to carry out work in the biomaterial space.
Future focused
Furnell says there is a diverse but complementary skillset between her, Kabbara and Savitri-Hampton.
“Sörzero was our proof point to see how well we can work together,” she says. “Products will always change and develop – but at the end of the day, the team stays the same.”
While Synbiote focuses on research and development, their operations will ramp up in 2025 as they continue integrating and optimising their biomaterials.
“I feel so lucky to be able to do this,” Furnell says.